We use cookies to ensure you get the best experience on our website. By continuing to browse, you agree to our use of cookies and our Privacy Policy
Posts
Intel Revenue Jumps 7% to $13.6B on AI Demand, Beats Es...
Intel reports Q1 revenue of $13.6 billion, up 7%, beating expectations as AI-dri...
Workspace Intelligence Powerful AI Upgrade in Google Docs
Workspace Intelligence brings proactive AI assistants to Google Docs and Sheets....
WhatsApp Prepaid Recharge Powerful New In-App Feature
WhatsApp prepaid recharge feature lets users recharge mobile plans directly in t...
AI Job Loss Shocking Study: Engineers More Worried
AI job loss concerns rise as an Anthropic study shows software engineers fear AI...
OpenAI Workspace Agents Powerful AI Update in ChatGPT
OpenAI workspace agents bring powerful agentic AI to ChatGPT. Explore features, ...
Hengrui Q1 2026 Profit Meets Expectations Amid Steady G...
Hengrui Q1 2026 profit results remain in line with expectations as China’s top d...
US FDA Approves Merck HIV Pill Combo, Expands Treatment...
US FDA approves Merck HIV pill combo Idvynso, offering a new once-daily treatmen...
India Silent Liver Epidemic: Why GLP-1 Drugs Alone Fall...
India silent liver epidemic GLP-1 drugs highlight rising fatty liver risk as exp...
IICT Dialysis Technology Cuts Costs, Benefits 20,000 Pa...
IICT dialysis technology cost reduction India brings affordable treatment as ind...
Gut Microbiome Parkinson Risk Gene Study Reveals Early ...
Gut microbiome Parkinson risk gene study shows early microbial changes in carrie...
India Ammonia Rule Hits Pharma as Supply Shift Hurts Dr...
India ammonia rule pharma impact grows as new directive shifts surplus ammonia t...
India Obesity Drug Market Booms as Pills Gain Popularity
India obesity drug market pills gain momentum as rising demand and Chinese drug ...
Merck & Co. Rivals Eye Deal for Inhibrx Cancer Drug Lin...
Merck Inhibrx cancer drug deal Keytruda gains momentum as pharma rivals explore ...
Roche Submits MS Drug Fenebrutinib Despite Trial Deaths
Roche MS drug fenebrutinib trial deaths raise safety concerns as the company sub...
Merck & Co., Eisai Cancer Drug Phase 3 Trial Misses Key...
Merck Eisai cancer drug Phase 3 trial misses primary endpoint, raising concerns ...
Car Finance Compensation Scheme Faces Legal Challenge, ...
The UK’s £7.5bn car finance compensation scheme faces a legal challenge over pay...